Caplin Point Laboratories Ltd. has earned a coveted place on Forbes Asia’s “200 Best Under a Billion” list for 2023.
The selection process involved evaluating over 20,000 publicly traded companies spanning the Asia-Pacific region. The chosen 200 enterprises share a common characteristic of maintaining annual sales under $1 billion.
The stringent selection criteria encompassed comprehensive assessments, including debt management, sales growth, earnings-per-share performance, and returns on equity.
However, the shares were down by 3.25 per cent to ₹1,028 at 12.41 pm on NSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.